The short answer
If a kidney biopsy report mentions glomerulosclerosis or interstitial fibrosis, it is describing areas of scarring in the kidney.
- Glomerulosclerosis means scarring of some kidney filtering units, called glomeruli.
- Interstitial fibrosis means scar tissue has developed in the tissue between the kidney’s tubules.
These findings can indicate chronic or previously established kidney injury, but they do not by themselves tell you how well your kidneys are functioning now or exactly what will happen in the future. The amount of scarring, the underlying kidney disease, current eGFR, urine protein, blood pressure, and whether there are also active inflammatory lesions all matter.
What does glomerulosclerosis mean?
The glomeruli are microscopic filtering units that remove waste and excess fluid from the blood.
Sclerosis means scarring or hardening of tissue. Therefore, glomerulosclerosis means that part or all of a glomerulus has been replaced by scar tissue.
A biopsy may describe:
- Focal glomerulosclerosis: only some glomeruli are affected.
- Global glomerulosclerosis: an entire glomerulus is scarred.
- Segmental sclerosis: only part of an individual glomerulus is scarred.
Glomerulosclerosis can occur in several kidney diseases. It can also develop as a response to long-standing stress or injury to the kidneys. Importantly, seeing the word “sclerosis” does not automatically mean you have primary FSGS (focal segmental glomerulosclerosis). The biopsy pattern must be interpreted alongside the clinical history and other biopsy findings.
What does interstitial fibrosis mean?
The kidney contains millions of tiny tubules that process the fluid filtered by the glomeruli. These tubules are surrounded by supporting tissue called the interstitium.
Interstitial fibrosis means that some of this normal tissue has been replaced by scar tissue.
Biopsy reports often mention interstitial fibrosis and tubular atrophy (IFTA) together.
- Interstitial fibrosis: scar tissue in the supporting tissue around the tubules.
- Tubular atrophy: tubules have become smaller and structurally damaged.
IFTA is an important indicator of chronic kidney damage. KDIGO notes that the amount of interstitial fibrosis and tubular atrophy is one of the most useful ways a biopsy assesses chronic irreversible damage.
Does scarring mean the kidney damage is permanent?
Scar tissue itself generally does not simply return to normal. That is why significant glomerulosclerosis or fibrosis is considered chronic damage.
But there is an important distinction:
Permanent scar tissue does not mean that all remaining kidney function is permanently lost.
A biopsy may show a mixture of:
- Active injury, which may respond to treatment
- Chronic scarring, which generally cannot be reversed
- Relatively preserved kidney tissue
Some active kidney diseases can improve substantially when the underlying cause is treated, even when a biopsy also shows some chronic scarring.
Why the percentage of scarring matters
Pathologists may report findings such as mild, moderate, or severe interstitial fibrosis and tubular atrophy, or give an estimated percentage of affected tissue.
In general, a larger amount of chronic scarring means there is less healthy kidney tissue available for recovery and may be associated with a greater risk of reduced kidney function.
However, a percentage should never be interpreted alone.
For example, two people can both have “20% fibrosis” but have very different kidney function, causes of disease, levels of proteinuria, blood pressure, and treatment options.
The biopsy is one piece of the picture.
What about active inflammation?
This is one of the most important parts of a biopsy report.
Kidney biopsies often distinguish between active lesions and chronic lesions.
Active inflammation or injury may sometimes respond to treatment. Chronic sclerosis and fibrosis generally represent established structural damage and are much less reversible.
That is why a report showing both inflammation and fibrosis does not necessarily mean “nothing can be done.”
The key question becomes:
How much of the kidney injury is active and potentially treatable, and how much represents established scarring?
What other results should be considered?
A kidney biopsy should be interpreted together with your clinical information, including:
- eGFR and creatinine
- Amount of urine albumin or protein
- Blood pressure
- Duration of kidney disease
- Previous kidney-function results
- Symptoms and medical history
- Diabetes or other underlying conditions
- Medication exposure
- Findings from the rest of the biopsy
Kidney biopsies are commonly examined using light microscopy, immunofluorescence, and sometimes electron microscopy because different techniques reveal different types of kidney injury.
Does glomerulosclerosis mean kidney failure is coming?
No.
The presence of glomerulosclerosis or interstitial fibrosis does not by itself mean that dialysis or kidney failure is inevitable.
Your current kidney function and its trend over time are important. Urine albumin or protein is also important because it provides information about ongoing kidney injury and risk.
A person with some biopsy-proven scarring may have stable kidney function for a long period, while another person with a similar biopsy finding may have progressive disease.
The underlying diagnosis matters greatly.
What should you ask your nephrologist?
After receiving a biopsy report, useful questions include:
- What is the exact kidney disease diagnosed by the biopsy?
- How much glomerulosclerosis is present?
- How much interstitial fibrosis and tubular atrophy is present?
- Are there active inflammatory lesions that may respond to treatment?
- What did the immunofluorescence and electron microscopy show?
- How do these findings fit with my eGFR and urine protein?
- Is the kidney disease currently active, chronic, or both?
- What can treatment realistically accomplish?
- How should my kidney function and urine protein be monitored?
These questions are often more useful than focusing on one alarming word in the pathology report.
Bottom line
Glomerulosclerosis and interstitial fibrosis are terms for kidney scarring. They generally indicate established structural injury, but they do not tell the entire story.
The most important interpretation is the combination of:
biopsy findings + active versus chronic injury + amount of scarring + eGFR trend + urine protein/albumin + underlying cause.
A biopsy showing fibrosis or sclerosis should therefore be taken seriously, but it should not automatically be interpreted as “my kidneys are failing” or “nothing can be done.” The goal is to identify what is still active and treatable, protect the remaining kidney function, and monitor the disease over time.